BiotechTV

@biotechtv.bsky.social

News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. ๐Ÿ“บ

๐“๐ก๐ž ๐’๐ญ๐ฎ๐๐ข๐จ ๐š๐ญ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ ๐’๐ช๐ฎ๐š๐ซ๐ž: Do you have unique expertise on a topic in biotech? Are you doing cutting edge research at your company or lab? If so, BiotechTV and @massbio.bsky.social want to help broadcast your story to the world.

๐€๐ซ๐จ๐ฎ๐ง๐ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ: Over the weeks and months ahead, BiotechTV is excited to present a new weekly series that will highlight the world capital of biotech, Kendall Square. Please tune in on X, Instagram, and TikTok.

๐Ž๐ฏ๐ž๐ซ๐ญ๐ข๐ฆ๐ž: Successful biotech entrepreneur Ron Renaud shares his advice for biotech operators today, and gives his take on the state of the industry.

๐๐ฎ๐ข๐œ๐ค ๐“๐š๐ค๐ž: Today it was announced that AbbVie will be acquiring the in-vivo CAR-T company Capstan Therapeutics for up to $2.1B. Brad Loncar shares his take on what the news could mean for the broader biotech sector.

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: Matt Gline speaks with Philip Ross, one of the most experienced and successful bankers in healthcare, about the M&A landscape and his decision to join Jefferies last year. Full video: www.biotechtv.com/post/off-tar...

๐‚๐€๐‘-๐“ ๐‹๐จ๐ ๐ข๐œ-๐†๐š๐ญ๐ข๐ง๐ : ArsenalBio CEO Ken Drazan describes the idea of logic-gating, which might allow CAR-T therapies to work in solid tumors when targeting more than one antigen is needed.

๐“๐ก๐ž ๐’๐ญ๐ฎ๐๐ข๐จ ๐š๐ญ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ ๐’๐ช๐ฎ๐š๐ซ๐ž: Biotech veteran @artkrieg.bsky.social explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP. Full video: www.biotechtv.com/post/zola-th...

๐๐ข๐จ๐ญ๐ž๐œ๐ก ๐‚๐„๐Ž ๐’๐ข๐ฌ๐ญ๐ž๐ซ๐ก๐จ๐จ๐: x4 Pharmaceuticals' CEO Paula Ragan on her career and running a commercial stage company in the rare disease space. Full video: www.biotechtv.com/post/paula-r...

๐“๐ก๐ž ๐’๐ญ๐ฎ๐๐ข๐จ ๐š๐ญ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ ๐’๐ช๐ฎ๐š๐ซ๐ž: Elias Zerhouni and Andy Plump discuss the future of multispecific biologics. Plus, career advice, biotech compared to pharma, and more. Full video: www.biotechtv.com/post/elias-z...

๐€๐ง๐ ๐ฅ๐จ ๐๐จ๐ซ๐๐ข๐œ ๐‹๐ข๐Ÿ๐ž ๐’๐œ๐ข๐ž๐ง๐œ๐ž ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž: Cure Parkinson's CEO Helen Matthews talks about their work, and participating in the International Linked Clinical Trials Initiative. Full video: www.biotechtv.com/post/cure-pa...

๐€๐ง๐ ๐ฅ๐จ ๐๐จ๐ซ๐๐ข๐œ ๐‹๐ข๐Ÿ๐ž ๐’๐œ๐ข๐ž๐ง๐œ๐ž ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž: Denmark based Synklino is developing a fusion protein that targets US28 for CMV infections from transplants. Full video: www.biotechtv.com/post/synklin...

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: On the heels of raising a $65M series B, the CEO of Flagship's Ampersand Biomedicines describes the company's precision medicine platform, and gives updates on partnering and R&D progress. Full video: www.biotechtv.com/post/ampersa...

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: After a $93M series B, Character Bio's CEO Cheng Zhang describes how the company has built a proprietary database to reclassify AMD patients into genetic subgroups to optimize trial patient selection. Full video: www.biotechtv.com/post/charact...

๐“๐ก๐ž ๐’๐ญ๐ฎ๐๐ข๐จ ๐š๐ญ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ ๐’๐ช๐ฎ๐š๐ซ๐ž: Candel Therapeutics CEO Paul Peter Tak and IDEA Pharma CEO Mike Rea on why they believe a different mindset and good communication are keys to succeeding with new innovations in biotech. Full video: www.biotechtv.com/post/the-stu...

๐๐ข๐จ๐“๐ซ๐ข๐ง๐ข๐ญ๐ฒ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“: AlveoGene Executive Chair David Hipkiss describes the company's unique inhaled gene therapy platform that fuses a Sendai virus and Lentivirus, and can be redosed. Full video: www.biotechtv.com/post/alveoge...

Last year BiotechTV launched three new regular thematic shows, with the goal of having unique programming by subject matter experts. They are: 1. The Studio at Kendall Square 2. BioVenture VoiCes with Chris Garabedian 3. Biotech CEO Sisterhood A fourth will be launched next week

Bild

๐’๐ญ๐š๐ซ๐ญ๐ข๐ง๐  ๐’๐ฎ๐ง๐๐š๐ฒ: Tune in to BiotechTV's coverage of the biggest week of the year!

Bild

๐’๐ญ๐š๐ซ๐ญ๐ข๐ง๐  ๐’๐š๐ญ๐ฎ๐ซ๐๐š๐ฒ: It's one of the biggest meetings for data of the year. And we'll be interviewing some of the industry's biggest leaders. Catch BiotechTV's coverage of #ASH24 from San Diego this Sat - Mon!

Bild